Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Wednesday, November 14, 2018 · 468,232,236 Articles · 3+ Million Readers

Detailed Research: Economic Perspectives on W.W. Grainger, Jabil, Grand Canyon Education, Sage Therapeutics, H. B. Fuller, and Jazz Pharmaceuticals — What Drives Growth in Today's Competitive Landscape

NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of W.W. Grainger, Inc. (NYSE:GWW), Jabil, Inc. (NYSE:JBL), Grand Canyon Education, Inc. (NASDAQ:LOPE), Sage Therapeutics, Inc. (NASDAQ:SAGE), H. B. Fuller Company (NYSE:FUL), and Jazz Pharmaceuticals PLC (NASDAQ:JAZZ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

/EIN News/ -- Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GWW DOWNLOAD: http://Fundamental-Markets.com/register/?so=GWW
JBL DOWNLOAD: http://Fundamental-Markets.com/register/?so=JBL
LOPE DOWNLOAD: http://Fundamental-Markets.com/register/?so=LOPE
SAGE DOWNLOAD: http://Fundamental-Markets.com/register/?so=SAGE
FUL DOWNLOAD: http://Fundamental-Markets.com/register/?so=FUL
JAZZ DOWNLOAD: http://Fundamental-Markets.com/register/?so=JAZZ

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine W.W. Grainger, Inc. (NYSE:GWW), Jabil, Inc. (NYSE:JBL), Grand Canyon Education, Inc. (NASDAQ:LOPE), Sage Therapeutics, Inc. (NASDAQ:SAGE), H. B. Fuller Company (NYSE:FUL), and Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 17th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

W.W. GRAINGER, INC. (GWW) REPORT OVERVIEW

W.W. Grainger's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, W.W. Grainger reported revenue of $2,860.21MM vs $2,615.27MM (up 9.37%) and analysts estimated basic earnings per share $4.19 vs $1.68 (up 149.40%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, W.W. Grainger reported revenue of $10,424.86MM vs $10,137.20MM (up 2.84%) and analysts estimated basic earnings per share $10.07 vs $9.94 (up 1.31%). Analysts expect earnings to be released on January 23rd, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $2.94. The estimated EPS forecast for the next fiscal year is $18.00 and is expected to report on January 23rd, 2019.

To read the full W.W. Grainger, Inc. (GWW) report, download it here: http://Fundamental-Markets.com/register/?so=GWW

-----------------------------------------

JABIL, INC. (JBL) REPORT OVERVIEW

Jabil's Recent Financial Performance

For the three months ended August 31st, 2018 vs August 31st, 2017, Jabil reported revenue of $5,771.83MM vs $5,023.03MM (up 14.91%) and analysts estimated basic earnings per share -$0.34 vs $0.26. For the twelve months ended August 31st, 2018 vs August 31st, 2017, Jabil reported revenue of $22,095.42MM vs $19,063.12MM (up 15.91%) and analysts estimated basic earnings per share $0.50 vs $0.71 (down 29.58%). Analysts expect earnings to be released on December 13th, 2018. The report will be for the fiscal period ending November 30th, 2018. Reported EPS for the same quarter last year was $0.51.

To read the full Jabil, Inc. (JBL) report, download it here: http://Fundamental-Markets.com/register/?so=JBL

-----------------------------------------

GRAND CANYON EDUCATION, INC. (LOPE) REPORT OVERVIEW

Grand Canyon Education's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Grand Canyon Education reported revenue of $236.82MM vs $218.30MM (up 8.48%) and analysts estimated basic earnings per share $0.97 vs $0.85 (up 14.12%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Grand Canyon Education reported revenue of $974.13MM vs $873.34MM (up 11.54%) and analysts estimated basic earnings per share $4.31 vs $3.22 (up 33.85%). Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.81. The estimated EPS forecast for the next fiscal year is $5.13 and is expected to report on February 20th, 2019.

To read the full Grand Canyon Education, Inc. (LOPE) report, download it here: http://Fundamental-Markets.com/register/?so=LOPE

-----------------------------------------

SAGE THERAPEUTICS, INC. (SAGE) REPORT OVERVIEW

Sage Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.97. The estimated EPS forecast for the next fiscal year is -$10.39 and is expected to report on February 28th, 2019.

To read the full Sage Therapeutics, Inc. (SAGE) report, download it here: http://Fundamental-Markets.com/register/?so=SAGE

-----------------------------------------

H. B. FULLER COMPANY (FUL) REPORT OVERVIEW

H. B. Fuller's Recent Financial Performance

For the three months ended August 31st, 2018 vs August 31st, 2017, H. B. Fuller reported revenue of $770.11MM vs $562.87MM (up 36.82%) and analysts estimated basic earnings per share $0.75 vs $0.50 (up 50.00%). For the twelve months ended November 30th, 2017 vs November 30th, 2016, H. B. Fuller reported revenue of $2,306.04MM vs $2,094.61MM (up 10.09%) and analysts estimated basic earnings per share $1.16 vs $2.48 (down 53.23%). Analysts expect earnings to be released on January 22nd, 2019. The report will be for the fiscal period ending November 30th, 2018. The reported EPS for the same quarter last year was $0.75. The estimated EPS forecast for the next fiscal year is $3.85 and is expected to report on January 22nd, 2019.

To read the full H. B. Fuller Company (FUL) report, download it here: http://Fundamental-Markets.com/register/?so=FUL

-----------------------------------------

JAZZ PHARMACEUTICALS PLC (JAZZ) REPORT OVERVIEW

Jazz Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Jazz Pharmaceuticals reported revenue of $500.48MM vs $394.39MM (up 26.90%) and analysts estimated basic earnings per share $1.53 vs $1.76 (down 13.07%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Jazz Pharmaceuticals reported revenue of $1,618.69MM vs $1,487.97MM (up 8.79%) and analysts estimated basic earnings per share $8.13 vs $6.56 (up 23.93%). Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $2.93. The estimated EPS forecast for the next fiscal year is $13.85 and is expected to report on February 26th, 2019.

To read the full Jazz Pharmaceuticals PLC (JAZZ) report, download it here: http://Fundamental-Markets.com/register/?so=JAZZ

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News